NZ333023A - Treatment of ischemia referfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction using pyridoxal-5'-phosphate, pyridoxine, pyridoxal and pyridoxamine - Google Patents

Treatment of ischemia referfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction using pyridoxal-5'-phosphate, pyridoxine, pyridoxal and pyridoxamine

Info

Publication number
NZ333023A
NZ333023A NZ33302398A NZ33302398A NZ333023A NZ 333023 A NZ333023 A NZ 333023A NZ 33302398 A NZ33302398 A NZ 33302398A NZ 33302398 A NZ33302398 A NZ 33302398A NZ 333023 A NZ333023 A NZ 333023A
Authority
NZ
New Zealand
Prior art keywords
pyridoxal
treatment
pyridoxamine
pyridoxine
ischemia
Prior art date
Application number
NZ33302398A
Inventor
Naranjan S Dhalla
Rajat Sethi
Krishnamurti Dakshinamurti
Original Assignee
Univ Manitoba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manitoba filed Critical Univ Manitoba
Publication of NZ333023A publication Critical patent/NZ333023A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Use of pyridoxal-5'-phosphate, pyridoxine, pyridoxal and pyridoxamine in the manufacture of a medicament for the treatment of ischemia referfusion injury and cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction
NZ33302398A 1998-07-09 1998-11-26 Treatment of ischemia referfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction using pyridoxal-5'-phosphate, pyridoxine, pyridoxal and pyridoxamine NZ333023A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11227798A 1998-07-09 1998-07-09

Publications (1)

Publication Number Publication Date
NZ333023A true NZ333023A (en) 2000-08-25

Family

ID=22343046

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ33302398A NZ333023A (en) 1998-07-09 1998-11-26 Treatment of ischemia referfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction using pyridoxal-5'-phosphate, pyridoxine, pyridoxal and pyridoxamine

Country Status (4)

Country Link
JP (1) JP2000026295A (en)
AU (2) AU759824B2 (en)
CA (1) CA2254528C (en)
NZ (1) NZ333023A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE293119T1 (en) * 2000-02-29 2005-04-15 Medicure Int Inc CARDIOPROTECTIVE PHOSPHONATES
EP1531157B1 (en) * 2000-02-29 2008-03-19 Medicure International Inc. Cardioprotective phosphonates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222664A (en) * 1986-11-29 1990-06-26 Vesta Med Pty Ltd Pharmaceutical compositions containing pyridoxal as a source of vitamin b6
JPH09221425A (en) * 1996-02-13 1997-08-26 Taiho Yakuhin Kogyo Kk Thiol protease inhibitor

Also Published As

Publication number Publication date
AU9421098A (en) 2000-02-03
AU759824B2 (en) 2003-05-01
JP2000026295A (en) 2000-01-25
AU2007202621A1 (en) 2007-06-28
CA2254528A1 (en) 2000-01-09
CA2254528C (en) 2007-07-17

Similar Documents

Publication Publication Date Title
WO2001013900A3 (en) Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
NZ514767A (en) Treatment of cardiovascular and related pathologies
GR3024465T3 (en) Substituted mono- and bipyridylmethylpyridone as angiotensine II antagonists.
IL85625A (en) Aminomethyl heterocyclic compounds,their preparation and their use as fungicides
MY101177A (en) Improvements in pharmaceutically acceptable salts
DE3781786T2 (en) PROSTHESIS FOR IMPLANTING IN THE UROGENITAL AREA'S HYPODERM TISSUE.
EP0715851A3 (en) Substituted phenylpyrimidine derivatives, useful in the treatment of prevention of CNS disorders
BG105843A (en) Heterocyclic aromatic compounds useful as growth hormone secretagogues
ZA952086B (en) Heterocyclic compounds their preparation and use
BG103556A (en) 3-pyridyl enantiomers and their application as analgetics
GEP20043162B (en) Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
USD452600S1 (en) Waist nipper
USD454423S1 (en) Girdle
NZ333023A (en) Treatment of ischemia referfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction using pyridoxal-5'-phosphate, pyridoxine, pyridoxal and pyridoxamine
EP1006793A4 (en) Anti-arrhythmic composition and methods of treatment
DE69108402D1 (en) 5-FLUOR-2,4,6-PYRIMIDINTHIAMINE DERIVATIVES TO PREVENT HAIR LOSS.
AU2001263955A1 (en) Vitamin b6 derivatives as protective components in the oxidative treatment of hair
DE3572489D1 (en) Indolophenanthridines, their preparation and use
HUT47985A (en) Movable track constructing machine for picking, cleaning and putting back again ballast
EP0311322A3 (en) Pyridine or pyridazine derivatives as cardio-protective agents and for the treatment of ischemic disease, and process for their preparation
USD453258S1 (en) Girdle
USD453059S1 (en) Girdle
HUT49873A (en) Herbicides and acaricides, as well as process for producing the active ingredient aryl- or heteroaryldione derivatives
GR852772B (en)
EP0355612A3 (en) New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: MEDICURE INC., CA

Free format text: OLD OWNER(S): UNIVERSITY OF MANITOBA

Owner name: THE UNIVERSITY OF MANITOBA, CA

Free format text: OLD OWNER(S): UNIVERSITY OF MANITOBA

RENW Renewal (renewal fees accepted)